TARSTarsus Pharmaceuticals Inc
TARS
Tarsus Pharmaceuticals Inc913
Mkt Cap
$3.09BVolume
1.0052W High
$85.2552W Low
$38.51PE Ratio
-45.08TARS Fundamentals
Price
$72.56Prev Close
$72.43Open
$72.7250D MA
$68.64Beta
0.75Avg. Volume
509,680.50EPS (Annual)
-$1.59P/B
8.99Rev/Employee
$1.22M$3,086.48
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the firm...
MarketBeat·3h ago
Capricorn Fund Managers Ltd Decreases Position in Tarsus Pharmaceuticals, Inc. $TARS
Capricorn Fund Managers Ltd lessened its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 90.8% during the 4th quarter, according to the company in its most recent Form 13F...
MarketBeat·7d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Upgraded to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Tarsus Pharmaceuticals from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·9d ago
Q2 EPS Estimate for Tarsus Pharmaceuticals Lifted by Analyst
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) - Lifesci Capital increased their Q2 2026 EPS estimates for shares of Tarsus Pharmaceuticals in a research note issued on Tuesday, March 24th...
MarketBeat·18d ago
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. lessened its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Free Report) by 9.6% in the 4th quarter, according to the company in its most recent 13F...
MarketBeat·19d ago
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade
Key PointsAn executive at Tarsus Pharmaceuticals sold 12,274 shares for a transaction value of approximately $839,000, based on a weighted average price of $68.36 per share across three days ending March 19, 2026...
Nasdaq News: Markets·20d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Sells $761,676.24 in Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) CEO Bobak Azamian sold 10,972 shares of the firm's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total value of $761,676.24. Following the completion of the transaction, the...
MarketBeat·24d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 390 Shares
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 390 shares of the firm's stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $67.00, for a total value of $26,130.00. Following the sale, the insider directly owned...
MarketBeat·24d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 375 Shares
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 375 shares of the business's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total transaction of $26,032.50. Following the transaction...
MarketBeat·24d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $26,041.09 in Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 379 shares of the company's stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $68.71, for a total transaction of $26,041.09. Following the completion of the...
MarketBeat·24d ago
<
1
2
...
>